Treatment of HER2-Positive Metastatic Breast Cancer

Lignende værker

• Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
  af: Swain, Sandra M., et al.
  Udgivet: (2015)
• Treatment of older patients with HER2-positive metastatic breast cancer with pertuzumab, trastuzumab, and docetaxel: subgroup analyses from a randomized, double-blind, placebo-controlled phase III trial (CLEOPATRA)
  af: Miles, David, et al.
  Udgivet: (2013)
• The changing treatment of metastatic her2-positive breast cancer
  af: Mitsogianni, Maria, et al.
  Udgivet: (2021)
• Overall survival benefit with pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer in CLEOPATRA, a randomised Phase 3 study
  af: Swain, Sandra M., et al.
  Udgivet: (2013)
• Palbociclib for the Treatment of Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer
  af: Morikawa, Aki, et al.
  Udgivet: (2015)